Monique Nolly Group

While often successful, medical tourism carries inherent risks that must be managed:

• Lack of Follow-Up Care: Once a patient returns home, their local doctor may be unfamiliar with the specific surgical techniques used abroad, making complication management difficult.

• Legal Recourse: In the event of medical malpractice, patients often find they have little to no legal standing to sue in a foreign jurisdiction.

• Travel Risks: Long-haul flights immediately after surgery increase the risk of Deep Vein Thrombosis (DVT) and pulmonary embolisms.

• Antibiotic Resistance: There is a documented risk of patients "bringing home" multi-drug resistant infections (superbugs) from foreign hospital environments.

Regulators (like the FDA or EMA) classify IVDs based on the risk posed by an incorrect result.

• Class I (Low Risk): Includes general laboratory equipment like specimen receptacles or basic culture media.

• Class II (Moderate Risk): Includes tests for common conditions like pregnancy, cholesterol, or blood glucose.

• Class III (High Personal/Public Risk): Includes tests for infectious diseases (HIV, Hepatitis), cancer markers, and genetic tests that determine life-altering treatments.

Managing the flow of visitors is a logistical and security challenge. Digital Visitor Management (DVM) kiosks have replaced paper logbooks.

Modern DVM systems perform "Instant Background Checks" against government databases or internal "Blacklists" of individuals who have previously been aggressive or are under a restraining order. Upon check-in, the system prints a temporary badge with a photo and an expiration "void" mark, ensuring that visitors cannot stay past their authorized time.

The "Wild West" era of mental health apps ended in 2024. By 2025, the FDA (US) and MHRA (UK) have established strict Qualification and Classification frameworks. Devices and software are categorized based on risk:

• Class I: Low-risk wellness/meditation apps (self-certified).

• Class II/III: High-risk diagnostic or treatment tools (requiring clinical trials).

In 2025, the "Deterioration Rate" (patients getting worse while using an app) is now a mandatory reporting metric. This focus on clinical safety has forced thousands of low-quality "wellness" apps out of the market, leaving a more robust, evidence-based selection for consumers and clinicians.